{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.5:c.140C>A",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "C",
            "alt": "A",
            "position": "140"
          },
          "Protein Change": {
            "ref": "H",
            "alt": "Q",
            "position": "47"
          },
          "Description in input context": "c.140C>A (p.H47Q)"
        },
        {
          "HGVS": "NM_000345.5:c.259G>T",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "G",
            "alt": "T",
            "position": "259"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "87"
          },
          "Description in input context": "c.259G>T (p.A87V)"
        },
        {
          "HGVS": "NM_000345.5:c.380C>A",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "C",
            "alt": "A",
            "position": "380"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "Q",
            "position": "127"
          },
          "Description in input context": "c.380C>A (p.P127Q)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005797"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro experiments using the 20S proteasome and liposomes",
      "Material used": {
        "Material Source": "Protein (α-synuclein)",
        "Material Name": "Human α-synuclein protein",
        "Description": ""
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.5:c.140C>A",
          "Conclusion": "Accelerated fibrillization",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The rate of formation of soluble oligomeric species was increased for the variant NM_000345.5:c.140C>A."
        },
        {
          "Variant": "NM_000345.5:c.259G>T",
          "Conclusion": "Accelerated fibrillization",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The rate of formation of soluble oligomeric species was increased for the variant NM_000345.5:c.259G>T."
        },
        {
          "Variant": "NM_000345.5:c.380C>A",
          "Conclusion": "Accelerated fibrillization",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The rate of formation of soluble oligomeric species was increased for the variant NM_000345.5:c.380C>A."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": ""
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": ""
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": ""
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}